Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bispebjerg Hospital
• Treatments: Eflornithine

Criteria

Inclusion Criteria:

• 18 years or older

• habile, understands Danish

• moderate to severe hirsutism prior to laser treatments

• succeeded minimum five laser treatments

• intact skin with no severe adverse events to laser treatments

• record of current medication and androgen hormone blood profile available

• Use of safe anti-conception (fertile women)

Exclusion Criteria:

• Pregnant or lactating

• allergy toward the content of Eflornithin cream

• Concomitant use of immunosuppressive therapy

• Dementia, psychiatric disease, alcoholic